Translation and validation of the Korean version of the 39-item Parkinson's disease questionnaire

Journal of Clinical Neurology (Korea)

Volumn 9, Issue 1, 2013, Pages 26-31

  Kwon, Do Young ^a   Kim, Jae Woo ^b   Ma, Hyeo Il ^c   Ahn, Tae Beom ^d   Cho, Jinwhan ^e   Lee, Phil Hyu ^f   Chung, Sun Ju ^g   Kim, Joong Seok ^h   Baik, Jong Sam ⁱ   Koh, Seong Beom ^a  

^a Korea University College of Medicine   (South Korea)

^b Dong A University College of Medicine   (South Korea)

^c Hallym University College of Medicine   (South Korea)

^d Kyung Hee University Hospital   (South Korea)

^e Sungkyunkwan University School of Medicine   (South Korea)

^f Yonsei University College of Medicine   (South Korea)

^g University of Ulsan College of Medicine   (South Korea)

^h The Catholic University of Korea College of Medicine   (South Korea)

ⁱ Inje University College of Medicine   (South Korea)

Author keywords

Parkinson's disease; Quality of life; Validation

Indexed keywords

EID: 84887842045     PISSN: 17386586     EISSN: 20055013     Source Type: Journal    
DOI: 10.3988/jcn.2013.9.1.26     Document Type: Article

References (35)

1. Saunders CD. Parkinson's Disease: A New Hope. Boston, MA: Harvard Health Publications, 2000.
2. Marttila RJ, Rinne UK. Epidemiology of Parkinson's disease in Finland. Acta Neurol Scand 1976;53:81-102.
3. Den Oudsten BL, Van Heck GL, De Vries J. Quality of life and related concepts in Parkinson's disease: A systematic review. Mov Disord 2007; 22:1528-1537.
4. Martinez-Martin P, Rodriguez-Blazquez C, Kurtis MM, Chaudhuri KR; NMSS Validation Group. The impact of non-motor symptoms on health-related quality of life of patients with Parkinson's disease. Mov Disord 2011;26:399-406.
5. Qin Z, Zhang L, Sun F, Fang X, Meng C, Tanner C, et al. Health related quality of life in early Parkinson's disease: Impact of motor and non-motor symptoms, results from Chinese levodopa exposed cohort. Parkinsonism Relat Disord 2009;15:767-771.
6. Uitti RJ. Treatment of Parkinson's disease: Focus on quality of life issues. Parkinsonism Relat Disord 2012;18 Suppl 1:S34-S36.
7. Jenkinson C, Fitzpatrick R, Peto V, Greenhall R, Hyman N. The Parkinson's Disease Questionnaire (PDQ-39): Development and validation of a Parkinson's disease summary index score. Age Ageing 1997;26: 353-357.
8. Peto V, Jenkinson C, Fitzpatrick R, Greenhall R. The development and validation of a short measure of functioning and well being for individuals with Parkinson's disease. Qual Life Res 1995;4:241-248.
9. Bushnell DM, Martin ML. Quality of life and Parkinson's disease: Translation and validation of the US Parkinson's Disease Questionnaire (PDQ-39). Qual Life Res 1999;8:345-350.
10. Martínez-Martín P, Frades Payo B. Quality of life in Parkinson's disease: Validation study of the PDQ-39 Spanish version. The Grupo Centro for Study of Movement Disorders. J Neurol 1998;245 Suppl 1:S34-S38.
11. Tsang KL, Chi I, Ho SL, Lou VW, Lee TM, Chu LW. Translation and validation of the standard Chinese version of PDQ-39: A quality-of-life measure for patients with Parkinson's disease. Mov Disord 2002;17: 1036-1040.
12. Katsarou Z, Bostantjopoulou S, Peto V, Alevriadou A, Kiosseoglou G. Quality of life in Parkinson's disease: Greek translation and validation of the Parkinson's disease questionnaire (PDQ-39). Qual Life Res 2001;10:159-163.
13. Luo W, Gui XH, Wang B, Zhang WY, Ouyang ZY, Guo Y, et al. Validity and reliability testing of the Chinese (mainland) version of the 39-item Parkinson's Disease Questionnaire (PDQ-39). J Zhejiang Univ Sci B 2010;11:531-538.
14. Hughes AJ, Daniel SE, Lees AJ. The clinical features of Parkinson's disease in 100 histologically proven cases. Adv Neurol 1993;60:595-599.
15. Langston JW, Widner H, Goetz CG, Brooks D, Fahn S, Freeman T, et al. Core assessment program for intracerebral transplantations (CAPIT). Mov Disord 1992;7:2-13.
16. Hoehn MM, Yahr MD. Parkinsonism: Onset, progression and mortality. Neurology 1967;17:427-442.
17. Movement Disorder Society Task Force on Rating Scales for Parkinson's Disease. The Unified Parkinson's Disease Rating Scale (UP-DRS): Status and recommendations. Mov Disord 2003;18:738-750.
18. Kang Y, Na DL, Hahn S. A validity study on the Korean Mini-Mental State Examination (K-MMSE) in dementia patients. J Korean Neurol Assoc 1997;15:300-308.
19. Johns MW. A new method for measuring daytime sleepiness: The Ep-worth sleepiness scale. Sleep 1991;14:540-545.
20. Chaudhuri KR, Martinez-Martin P, Brown RG, Sethi K, Stocchi F, Odin P, et al. The metric properties of a novel non-motor symptoms scale for Parkinson's disease: Results from an international pilot study. Mov Disord 2007;22:1901-1911.
21. Soh SE, Morris ME, McGinley JL. Determinants of health-related quality of life in Parkinson's disease: A systematic review. Parkinsonism Relat Disord 2011;17:1-9.
22. Carod-Artal FJ, Martinez-Martin P, Vargas AP. Independent validation of SCOPA-psychosocial and metric properties of the PDQ-39 Brazilian version. Mov Disord 2007;22:91-98.
23. Chapuis S, Ouchchane L, Metz O, Gerbaud L, Durif F. Impact of the motor complications of Parkinson's disease on the quality of life. Mov Disord 2005;20:224-230.
24. Chrischilles EA, Rubenstein LM, Voelker MD, Wallace RB, Rodnitzky RL. Linking clinical variables to health-related quality of life in Parkinson's disease. Parkinsonism Relat Disord 2002;8:199-209.
25. Gómez-Esteban JC, Zarranz JJ, Lezcano E, Tijero B, Luna A, Velasco F, et al. Influence of motor symptoms upon the quality of life of pa-tients with Parkinson's disease. Eur Neurol 2007;57:161-165.
26. Cronbach LJ. Coefficient alpha and the internal structure of tests. Psychometrika 1951;16:297-334.
27. Schrag A, Jahanshahi M, Quinn N. What contributes to quality of life in patients with Parkinson's disease? J Neurol Neurosurg Psychiatry 2000;69:308-312.
28. Schrag A, Selai C, Mathias C, Low P, Hobart J, Brady N, et al. Measuring health-related quality of life in MSA: The MSA-QoL. Mov Disord 2007;22:2332-2338.
29. Schrag A. Quality of life and depression in Parkinson's disease. J Neurol Sci 2006;248:151-157.
30. Muslimovic D, Post B, Speelman JD, Schmand B, de Haan RJ; CAR-PA Study Group. Determinants of disability and quality of life in mild to moderate Parkinson disease. Neurology 2008;70:2241-2247.
31. Qin Z, Zhang L, Sun F, Liu H, Fang X, Chan P, et al. Depressive symptoms impacting on health-related quality of life in early Parkinson's disease: Results from Chinese L-dopa exposed cohort. Clin Neurol Neurosurg 2009;111:733-737.
32. Rahman S, Griffin HJ, Quinn N., Jahanshahi M. Quality of life in Parkinson's disease: The relative importance of the symptoms. Mov Disord 2008;23:1428-1434.
33. Winter Y, von Campenhausen S, Gasser J, Seppi K, Reese JP, Pfeiffer KP, et al. Social and clinical determinants of quality of life in Parkinson's disease in Austria: A cohort study. J Neurol 2010;257:638-645.
34. Hagell P, Whalley D, McKenna SP, Lindvall O. Health status measure-ment in Parkinson's disease: Validity of the PDQ-39 and Nottingham Health Profile. Mov Disord 2003;18:773-783.
35. McHorney CA, Ware JEJr, Lu JF, Sherbourne CD. The MOS 36-item Short-Form Health Survey (SF-36): III. Tests of data quality, scaling assumptions, and reliability across diverse patient groups. Med Care 1994;32:40-66.